Skip to Main Content

Paper Details

Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials.
Liver Int
7
2018
HCV, HCV mono, HCV/HIV co-infection, HIV, LDV, Ledipasvir, NS5A, RBV, SOF, chronic hepatitis C virus, cirrhosis, cirrhotic, fatigue, headache, hepatitis C virus, ledipasvir, participants, patients, ribavirin, sofosbuvir

Datasets

Release 1.2